Seguir
Matthias Liechti
Matthias Liechti
University Hospital Basel
Email confirmado em usb.ch
Título
Citado por
Citado por
Ano
Pharmacological characterization of designer cathinones in vitro
LD Simmler, TA Buser, M Donzelli, Y Schramm, LH Dieu, J Huwyler, ...
British journal of pharmacology 168 (2), 458-470, 2013
7322013
Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naıve healthy volunteers
FX Vollenweider, A Gamma, M Liechti, T Huber
Neuropsychopharmacology 19 (4), 241-251, 1998
6051998
Acute effects of lysergic acid diethylamide in healthy subjects
Y Schmid, F Enzler, P Gasser, E Grouzmann, KH Preller, FX Vollenweider, ...
Biological psychiatry 78 (8), 544-553, 2015
4502015
Gender differences in the subjective effects of MDMA
ME Liechti, A Gamma, FX Vollenweider
Psychopharmacology 154, 161-168, 2001
4452001
The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation
KH Preller, M Herdener, T Pokorny, A Planzer, R Kraehenmann, ...
Current Biology 27 (3), 451-457, 2017
3772017
MDMA enhances emotional empathy and prosocial behavior
CM Hysek, Y Schmid, LD Simmler, G Domes, M Heinrichs, C Eisenegger, ...
Social cognitive and affective neuroscience 9 (11), 1645-1652, 2014
3642014
Acute psychological effects of 3, 4-methylenedioxymethamphetamine (MDMA,“Ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram
ME Liechti, C Baumann, A Gamma, FX Vollenweider
Neuropsychopharmacology 22 (5), 513-521, 2000
3382000
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling
ME Liechti
Swiss medical weekly 145, w14043, 2015
2942015
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
A Rickli, OD Moning, MC Hoener, ME Liechti
European Neuropsychopharmacology 26 (8), 1327-1337, 2016
2932016
LSD acutely impairs fear recognition and enhances emotional empathy and sociality
PC Dolder, Y Schmid, F Müller, S Borgwardt, ME Liechti
Neuropsychopharmacology 41 (11), 2638-2646, 2016
2872016
Psychological and physiological effects of MDMA (“Ecstasy”) after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
ME Liechti, MR Saur, A Gamma, D Hell, FX Vollenweider
Neuropsychopharmacology 23 (4), 396-404, 2000
2872000
To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students
LJ Maier, ME Liechti, F Herzig, MP Schaub
PloS one 8 (11), e77967, 2013
2692013
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
ME Liechti, FX Vollenweider
Human Psychopharmacology: Clinical and Experimental 16 (8), 589-598, 2001
2672001
Modern clinical research on LSD
ME Liechti
Neuropsychopharmacology 42 (11), 2114-2127, 2017
2642017
Long-lasting subjective effects of LSD in normal subjects
Y Schmid, ME Liechti
Psychopharmacology 235, 535-545, 2018
2342018
Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
LD Simmler, A Rickli, MC Hoener, ME Liechti
Neuropharmacology 79, 152-160, 2014
2312014
Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence
ME Liechti, L Lhuillier, K Kaupmann, A Markou
Journal of Neuroscience 27 (34), 9077-9085, 2007
2172007
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones
A Rickli, MC Hoener, ME Liechti
European Neuropsychopharmacology 25 (3), 365-376, 2015
2142015
Alterations of consciousness and mystical-type experiences after acute LSD in humans
ME Liechti, PC Dolder, Y Schmid
Psychopharmacology 234, 1499-1510, 2017
2112017
Designer drugs: mechanism of action and adverse effects
D Luethi, ME Liechti
Archives of toxicology 94 (4), 1085-1133, 2020
2072020
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20